Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Patients with haematological malignancies (HM) are at high risk of developing invasive fungal disease (IFD) with high morbidity and attributable mortality. We reviewed data published until September 2021 to update the 2017 antifungal prophylaxis recommendations of the German Society of Haematology a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stemler, Jannik, Mellinghoff, Sibylle C, Khodamoradi, Yascha, Sprute, Rosanne, Classen, Annika Y, Zapke, Sonja E, Hoenigl, Martin, Krause, Robert, Schmidt-Hieber, Martin, Heinz, Werner J, Klein, Michael, Koehler, Philipp, Liss, Blasius, Koldehoff, Michael, Buhl, Christoph, Penack, Olaf, Maschmeyer, Georg, Schalk, Enrico, Lass-Flörl, Cornelia, Karthaus, Meinolf, Ruhnke, Markus, Cornely, Oliver A, Teschner, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393896/
https://www.ncbi.nlm.nih.gov/pubmed/37311136
http://dx.doi.org/10.1093/jac/dkad143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393896/
https://www.ncbi.nlm.nih.gov/pubmed/37311136
http://dx.doi.org/10.1093/jac/dkad143

Ejemplares similares